oxipit Press Releases

Published on June 5, 2025 - 11:27 GMT

Oxipit partners with Vestre Viken to pilot AI in chest X-ray diagnostics

Oxipit and Vestre Viken launch Norway’s first pilot of AI for chest X-rays, combining autonomous reporting and decision support to improve diagnostic workflows. BæRUM, NORWAY, June 5, 2025 /⁨EINPresswire.com⁩/ -- Oxipit, a leading provider of AI-driven …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 17, 2025 - 09:28 GMT

Unilabs Partners with Oxipit to Integrate AI-Powered Chest X-Ray Solutions Across Europe

This partnership integrates Oxipit’s AI into Unilabs’ radiology workflows, streamlining chest X-ray reporting with automated triage and second-reading. GENEVA, SWITZERLAND, February 17, 2025 /⁨EINPresswire.com⁩/ -- February 17, 2025 — Geneva, Switzerland …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 19, 2023 - 09:28 GMT

LUMC deploys new Oxipit AI application for CT PE detection

Leiden University Medical Center expands cooperation with Oxipit by deploying company's AI quality assurance tool for CT Pulmonary Embolism (PE). VILNIUS, LITHUANIA, October 19, 2023 /⁨EINPresswire.com⁩/ -- Leiden University Medical Center (The …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 2, 2023 - 11:39 GMT

Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products

CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink, Quality and ChestEye. VILNIUS, LITHUANIA, March 2, 2023 /⁨EINPresswire.com⁩/ -- At the European Congress of Radiology in Vienna Oxipit announced that its diagnostic …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...

Published on February 15, 2023 - 12:17 GMT

Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite

The regulatory approval paves the way for ChestEye deployments in the Brazilian market. VILNIUS, LITHUANIA, February 15, 2023 /⁨EINPresswire.com⁩/ -- ChestEye application is already cleared for use in Europe and Australia. The Brazilian Health Regulatory …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 19, 2023 - 16:16 GMT

Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging

AI medical imaging company Oxipit closed a $4.9M funding round led by Taiwania Capital, Practica Capital, and Coinvest Capital. VILNIUS, LITHUANIA, January 19, 2023 /⁨EINPresswire.com⁩/ -- AI medical imaging company Oxipit closed a $4.9M funding round …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 21, 2022 - 12:26 GMT

Oxipit Introduces Quality Assurance for MSK, MG, and CT Modalities

AI medical imaging company Oxipit expanded its Quality product suite with quality assurance support for MSK X-rays, mammography images and lung CT scans. VILNIUS, LITHUANIA, November 21, 2022 /⁨EINPresswire.com⁩/ -- Previously supporting only chest X-rays …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...

Published on September 28, 2022 - 11:32 GMT

Kaunas city polyclinic picks ChestLink to speed up preventative health checks

With ChestLink healthy patients can be instantly sent home after the examination, without the need to wait for the study report at the polyclinic. VILNIUS, LITHUANIA, September 28, 2022 /⁨EINPresswire.com⁩/ -- Operating with 99.9% sensitivity, ChestLink …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...

Published on July 13, 2022 - 12:00 GMT

Chest Experts Oxipit And contextflow Team Up For Diagnostic Quality Assurance

The new partnership aims to mitigate the risk associated with missed findings in CT medical imaging studies. VILNIUS, LITHUANIA, July 13, 2022 /⁨EINPresswire.com⁩/ -- The new partnership aims to mitigate the risk associated with missed findings in CT …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on July 12, 2022 - 13:33 GMT

Study: 1 in 552 CXR Studies Feature Clinically Significant Diagnostic Errors

At ECR2022 Oxipit will present a retrospective validation study from internal ChestEye Quality performance data at more than 10 pilot deployment institutions. VILNIUS, LITHUANIA, July 12, 2022 /⁨EINPresswire.com⁩/ -- For the annual European Congress of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 25, 2022 - 11:35 GMT

ChestLink Autonomous AI Application Misses No Critical Findings In Real-World Clinical Test

Researchers in Finland release a preprint of a study on ChestLink autonomous AI application performance on real-world clinical data. VILNIUS, LITHUANIA, May 25, 2022 /⁨EINPresswire.com⁩/ -- Following the CE certification of the first autonomous AI medical …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 26, 2022 - 14:33 GMT

Oxipit and AstraZeneca Join Forces to Aid Early Lung Cancer Detection

The companies conducted a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed for improved pulmonary nodule detection. VILNIUS, LITHUANIA, April 26, 2022 /⁨EINPresswire.com⁩/ -- ChestEye Quality AI software was deployed in two …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 29, 2022 - 13:52 GMT

Oxipit Awarded CE Mark For The First Autonomous AI Medical Imaging Application

It is the first regulatory approved AI medical imaging application to perform diagnostics autonomously without any involvement from a radiologist. VILNIUS, LITHUANIA, March 29, 2022 /⁨EINPresswire.com⁩/ -- AI medical imaging application developer Oxipit …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 2, 2021 - 10:51 GMT

Oxipit to preview first autonomous AI medical imaging application at ECR

The application automatically identifies chest X-ray images with no abnormality and produces finalized reports without any intervention from the radiologist. VILNIUS, LITHUANIA, March 2, 2021 /⁨EINPresswire.com⁩/ -- The AI medical imaging company will …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

The Newsroom of Oxipit